Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
Details for Australian Patent Application No. 2009201236 (hide)
International Classifications
Event Publications
23 April 2009 Application Open to Public Inspection
Published as AU-B-2009201236
23 April 2009 Complete Application Filed
26 May 2011 Application Accepted
Published as AU-B-2009201236
22 September 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser